Navigation Links
Sigma-Aldrich Aligns Into Three New Market-Focused Business Units
Date:11/19/2012

ST. LOUIS, Nov. 19, 2012 /PRNewswire/ -- Effective January 1, 2013, Sigma-Aldrich Corporation (NASDAQ: SIAL) will align its organization into three market-focused business units that are defined by the customers and markets they serve.  This new organization will enable Sigma-Aldrich to better address the needs of its global customers and to further drive global sales growth.

Frank Wicks will transition from his current role as President of the Research business to become President of the new Applied Markets Business Unit.  This business unit will serve customers in Diagnostics, Testing and Industrial markets.

Eric Green will transition from his current role as Vice President and Managing Director of the International region (APLA) to become President of the newly structured Research Markets Business Unit.  This business unit will focus on broadening the offering of research products to scientists in Life Science, Academic, Government and Hospital settings around the world.  Eric will continue to have responsibility for the Latin America region as well.

Gilles Cottier will continue to lead the SAFC business.  This business will be renamed the SAFC Commercial Markets Business Unit and will continue to serve customers in the Life Science and Electronic markets.

Gerrit van den Dool will transition from his current role as Managing Director of the North American region (United States and Canada) to become Managing Director of the European region (EMEA).  Gerrit will relocate to St. Gallen, Switzerland.  Jason Apter will transition from his role of Chief of Staff to become Managing Director of the Asia Pacific region and will relocate to Singapore.  Customers in the North American region will be managed directly by the three business units – Applied Markets, Research Markets and SAFC Commercial Markets.

Sigma-Aldrich intends to provide more information about the structure, sales and growth prospects of each of the three business units early in 2013 in conjunction with its year-end financial results release.

About Sigma-Aldrich:  Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical and organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing.  Sigma-Aldrich customers include more than one million scientists and technologists in life science companies, university and government institutions, hospitals and industry.  The Company operates in 38 countries and has approximately 9,000 employees whose objective is to provide excellent service worldwide.  Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science, High Technology and Service.  For more information about Sigma-Aldrich, please visit its website, at www.sigma-aldrich.com.


'/>"/>
SOURCE Sigma-Aldrich Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
2. Sigma-Aldrich Accelerates Analytical Research and Extends Benefits of Fused-Core Particle Technology to All HPLC Users with the Launch of New Ascentis Express 5 Micron Particle by Supelco
3. Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences
4. Sigma-Aldrich Enhances Customer Focus in China - Unveils Dynamic New Website and Expands Product Offering Through Vetec Brand
5. Sigma-Aldrich (NASDAQ: SIAL) Declares $0.20 Quarterly Dividend
6. Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
7. Avanir Pharmaceuticals To Present at Three Conferences In May
8. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
9. LifeLearn wins awards for three multimedia education programs
10. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
11. Henry Schein Completes Three Acquisitions To Advance Strategic Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... 2017 According to a study conducted by ... to witness a CAGR of 6.5% during the forecast period 2016-2024. ... continue to be the leading market for cryotherapy globally during the ... Highlights ... ensuring affordable and adequate supply of gas in order to provide ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... ... enhance people’s everyday lives, recently attended the January ECRM Trade Show in Hilton ... is known for its large range of supplements that keep the body functioning ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: ... who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the ... an educator interacting with countless women who had little knowledge of the female characters ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: ... published author, Sara Seymour, who lives in Lafayette, Indiana where she works in a ... iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book ...
(Date:1/19/2017)... (PRWEB) , ... January 20, 2017 , ... Today, the ... to participate in four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who ... patients. APMs are an important part of the Administration’s effort to build a ...
(Date:1/19/2017)... , ... January 19, 2017 , ... This month, the ... that the name of their drug rehab center in Delray Beach, Florida has been ... that not only stars such as Philip Seymour Hoffman and Chris Farley are dying ...
Breaking Medicine News(10 mins):